Verdence Capital Advisors LLC Abbott Laboratories Transaction History

Verdence Capital Advisors LLC

$1.23 Billion
Q3 2024

A detailed history of Verdence Capital Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 29,027 shares of ABT stock, worth $3.36 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

29,027

Previous 28,188 2.98%

Holding current value

$3.36 Million

Previous $2.93 Million 12.97%

% of portfolio

0.27%

Previous 0.27%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$100.07 - $118.13 $83,958 - $99,111	839 Added 2.98%	29,027 $3.31 Million
Q2 2024 Jul 25, 2024	BUY	$100.73 - $112.44 $95,592 - $106,705	949 Added 3.48%	28,188 $2.93 Million
Q1 2024 Apr 25, 2024	SELL	$109.52 - $120.96 $2,080 - $2,298	-19 Reduced 0.07%	27,239 $3.1 Million
Q4 2023 Jan 31, 2024	BUY	$90.19 - $110.4 $487,657 - $596,932	5,407 Added 24.74%	27,258 $3 Million
Q3 2023 Oct 25, 2023	BUY	$95.53 - $114.62 $248,951 - $298,699	2,606 Added 13.54%	21,851 $2.12 Million
Q2 2023 Jul 28, 2023	SELL	$100.78 - $112.29 $66,917 - $74,560	-664 Reduced 3.34%	19,245 $2.1 Million
Q1 2023 Apr 24, 2023	BUY	$96.86 - $114.01 $361,094 - $425,029	3,728 Added 23.04%	19,909 $2.02 Million
Q4 2022 Jan 20, 2023	SELL	$95.06 - $111.52 $677,302 - $794,580	-7,125 Reduced 30.57%	16,181 $0
Q3 2022 Nov 15, 2022	BUY	$96.76 - $112.03 $17,416 - $20,165	180 Added 0.78%	23,306 $2.26 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $182,501 - $220,585	1,788 Added 8.38%	23,126 $2.51 Million
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $402,262 - $490,533	3,528 Added 19.81%	21,338 $2.53 Million
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $66,776 - $81,763	578 Added 3.35%	17,810 $2.51 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $12,015 - $13,293	-103 Reduced 0.59%	17,232 $2.04 Million
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $2,750 - $3,237	26 Added 0.15%	17,335 $2.01 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $194,497 - $229,147	1,787 Added 11.51%	17,309 $2.07 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $400,890 - $436,855	3,818 Added 32.62%	15,522 $1.7 Million
Q3 2020 Nov 09, 2020	BUY	$91.64 - $111.29 $125,638 - $152,578	1,371 Added 13.27%	11,704 $1.27 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $49,540 - $63,406	647 Added 6.68%	10,333 $945,000
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $110,814 - $162,041	1,764 Added 22.27%	9,686 $764,000
Q4 2019 Feb 03, 2020	BUY	$78.51 - $87.4 $25,908 - $28,842	330 Added 4.35%	7,922 $688,000
Q3 2019 Mar 06, 2020	SELL	$81.84 - $88.74 $34,454 - $37,359	-421 Reduced 5.25%	7,592 $635,000
Q2 2019 Mar 02, 2020	BUY	$72.88 - $85.0 $291 - $340	4 Added 0.05%	8,013 $674,000
Q1 2019 Mar 02, 2020	SELL	$66.22 - $80.06 $7,747 - $9,367	-117 Reduced 1.44%	8,009 $640,000
Q4 2018 Feb 25, 2020	SELL	$65.56 - $74.27 $19,930 - $22,578	-304 Reduced 3.61%	8,126 $588,000
Q3 2018 Feb 25, 2020	SELL	$60.81 - $73.36 $204,139 - $246,269	-3,357 Reduced 28.48%	8,430 $618,000
Q2 2018 Feb 11, 2020	SELL	$57.57 - $63.54 $39,896 - $44,033	-693 Reduced 5.55%	11,787 $719,000
Q1 2018 Jan 30, 2020	SELL	$56.27 - $63.62 $209,943 - $237,366	-3,731 Reduced 23.02%	12,480 $748,000
Q4 2017 Jan 30, 2020	BUY	$53.68 - $57.47 $870,206 - $931,646	16,211	16,211 $925,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account

Verdence Capital Advisors LLC Abbott Laboratories Transaction History